DENTSPLY SIRONA (NASDAQ:XRAY) Rating Reiterated by Barrington Research

DENTSPLY SIRONA (NASDAQ:XRAY)‘s stock had its “outperform” rating reissued by equities research analysts at Barrington Research in a report issued on Thursday, Benzinga reports. They currently have a $41.00 price objective on the medical instruments supplier’s stock. Barrington Research’s price target would suggest a potential upside of 34.43% from the company’s current price.

Other equities analysts have also issued research reports about the stock. Needham & Company LLC reaffirmed a “buy” rating and set a $42.00 price target on shares of DENTSPLY SIRONA in a research report on Thursday, February 29th. Leerink Partnrs reaffirmed an “outperform” rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. Piper Sandler upped their price target on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the stock a “neutral” rating in a research report on Friday, January 12th. SVB Leerink initiated coverage on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. They set an “outperform” rating and a $42.00 price target for the company. Finally, StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, January 19th. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Moderate Buy” and an average price target of $39.50.

DENTSPLY SIRONA Stock Up 0.2 %

Shares of NASDAQ XRAY opened at $30.50 on Thursday. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.38 and a quick ratio of 0.95. The company has a market capitalization of $6.32 billion, a PE ratio of -49.19, a price-to-earnings-growth ratio of 1.23 and a beta of 0.98. The firm’s 50-day moving average is $32.79 and its two-hundred day moving average is $32.84. DENTSPLY SIRONA has a 12-month low of $26.27 and a 12-month high of $43.24.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.01. The business had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $972.61 million. DENTSPLY SIRONA had a negative net margin of 3.33% and a positive return on equity of 11.14%. The company’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.46 earnings per share. Equities analysts anticipate that DENTSPLY SIRONA will post 2.05 EPS for the current fiscal year.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Macquarie Group Ltd. increased its stake in DENTSPLY SIRONA by 3.2% during the 2nd quarter. Macquarie Group Ltd. now owns 8,879 shares of the medical instruments supplier’s stock worth $318,000 after buying an additional 274 shares during the period. Parkside Financial Bank & Trust increased its stake in DENTSPLY SIRONA by 33.3% during the 4th quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock worth $42,000 after buying an additional 292 shares during the period. Beach Investment Counsel Inc. PA increased its stake in DENTSPLY SIRONA by 1.4% during the 4th quarter. Beach Investment Counsel Inc. PA now owns 22,125 shares of the medical instruments supplier’s stock worth $787,000 after buying an additional 306 shares during the period. Wahed Invest LLC increased its stake in DENTSPLY SIRONA by 9.3% during the 4th quarter. Wahed Invest LLC now owns 3,603 shares of the medical instruments supplier’s stock worth $128,000 after buying an additional 306 shares during the period. Finally, Tokio Marine Asset Management Co. Ltd. grew its holdings in DENTSPLY SIRONA by 5.4% during the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 6,950 shares of the medical instruments supplier’s stock worth $237,000 after acquiring an additional 359 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.